Tobradex and Weakness - a phase IV clinical study of FDA data
Weakness is found among people who take Tobradex, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Tobradex and have Weakness. It is created by eHealthMe based on reports of 2,400 people who have side effects when taking Tobradex from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
2,400 people reported to have side effects when taking Tobradex.
Among them, 121 people (5.04%) have Weakness.
What is Tobradex?
Tobradex has active ingredients of dexamethasone; tobramycin. It is often used in eye infection. eHealthMe is studying from 2,436 Tobradex users for its effectiveness, alternative drugs and more.
What is Weakness?
Weakness is found to be associated with 5,041 drugs and 5,930 conditions by eHealthMe.
Number of Tobradex and Weakness reports submitted per year:
Time on Tobradex when people have Weakness *:
Gender of people who have Weakness when taking Tobradex*:
Age of people who have Weakness when taking Tobradex *:
Common drugs people take besides Tobradex *:
Common side effects people have besides Weakness *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Tobradex and have Weakness?Check whether Weakness is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of Tobradex:
- Tobradex (2,436 reports)
Weakness treatments and more:
- Weakness (474,656 reports)
COVID vaccines that are related to Weakness:
- Weakness in Moderna COVID Vaccine
- Weakness in Pfizer BioNTech Covid Vaccine
- Weakness in Johnson and Johnson Covid Vaccine
How severe was Weakness and when was it recovered:
Expand to all the drugs that have ingredients of dexamethasone; tobramycin:
Common drugs associated with Weakness:
All the drugs that are associated with Weakness:
- Weakness (5,041 drugs)
Common conditions associated with Weakness:
All the conditions that are associated with Weakness:
- Weakness (5,930 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on dexamethasone; tobramycin (the active ingredients of Tobradex) and Tobradex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.